CAS 491833-29-5 appears in our catalog under these names: Eliglustat, Eliglustat/ 99.71% (existing batch purity), Eliglustat 98%, N-[(1R,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide, 98%, 98%, Eliglustat, 99.75%. Offered by: GLPBio, TRC, Mikromol, TargetMol, Biosynth. Available pack sizes: 5mg, 250mg, 1mg, 2mg, 10mg, 25mg, 50mg, 100mg.
Eliglustat is a carboxamide obtained by formal condensation of the carboxy group of octanoic acid with the primary amino group of (1R,2R)-2-amino-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(pyrrolidin-1-yl)propan-1-ol. A ceramide glucosyltransferase inhibitor used (as its tartrate salt) for treatment of Gaucher's disease. It has a role as an EC 2.4.1.80 (ceramide glucosyltransferase) inhibitor. It is a secondary alcohol, a carboxamide, a N-alkylpyrrolidine and a benzodioxine. It is a conjugate base of an eliglustat(1+).
Source: ChEBI
| Molecular formula | C23H36N2O4 |
|---|---|
| Molecular weight | 404.5 g/mol |
| IUPAC name | N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]octanamide |
| InChIKey | FJZZPCZKBUKGGU-AUSIDOKSSA-N |
| SMILES | CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O |
Computed by PubChem (NCBI)